Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0TE5Q
|
||||
Former ID |
DNC013271
|
||||
Drug Name |
Threo-1-aza-5-phenyl[4.4.0]decane hydrochloride
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C15H22ClN
|
||||
Canonical SMILES |
C1CCN2CCCC(C2C1)C3=CC=CC=C3.Cl
|
||||
InChI |
1S/C15H21N.ClH/c1-2-7-13(8-3-1)14-9-6-12-16-11-5-4-10-15(14)16;/h1-3,7-8,14-15H,4-6,9-12H2;1H/t14-,15-;/m1./s1
|
||||
InChIKey |
LDFFZPCCAMAFIV-CTHHTMFSSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Sodium-dependent serotonin transporter | Target Info | Inhibitor | [1] | |
Sodium-dependent dopamine transporter | Target Info | Inhibitor | [1] | ||
KEGG Pathway | Serotonergic synapsehsa04728:Dopaminergic synapse | ||||
Parkinson's disease | |||||
Cocaine addiction | |||||
Amphetamine addiction | |||||
Alcoholism | |||||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | 5HT1 type receptor mediated signaling pathway | ||||
5HT2 type receptor mediated signaling pathway | |||||
5HT3 type receptor mediated signaling pathway | |||||
5HT4 type receptor mediated signaling pathwayP00001:Adrenaline and noradrenaline biosynthesis | |||||
Parkinson disease | |||||
Dopamine receptor mediated signaling pathway | |||||
Pathway Interaction Database | Alpha-synuclein signaling | ||||
Reactome | Na+/Cl- dependent neurotransmitter transporters | ||||
WikiPathways | Monoamine Transport | ||||
SIDS Susceptibility Pathways | |||||
NRF2 pathway | |||||
Synaptic Vesicle Pathway | |||||
Serotonin Transporter ActivityWP727:Monoamine Transport | |||||
Dopaminergic Neurogenesis | |||||
Parkinsons Disease Pathway | |||||
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds | |||||
Neurotransmitter Clearance In The Synaptic Cleft | |||||
References | |||||
REF 1 | J Med Chem. 2007 May 31;50(11):2718-31. Epub 2007 May 10.Synthesis and pharmacology of site-specific cocaine abuse treatment agents: restricted rotation analogues of methylphenidate. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.